Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sperm-I-Prove
- Development stage
- Unknown
- Lead developer
- Delfran Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Sperm-I-Prove is an oral nutraceutical supplement developed by Delfran Pharmaceuticals to support male reproductive health and improve sperm quality. It is formulated with a combination of essential vitamins and minerals, including Vitamin C, Vitamin E, Zinc, and Folic acid. The supplement primarily functions through the antioxidant properties of Vitamin C and Vitamin E, which protect sperm from oxidative damage caused by reactive oxygen species. It is intended for men experiencing fertility concerns and is typically used for at least three months to align with the natural spermatogenesis cycle to improve sperm count and quality.
- Brand names
- Sperm-I-Prove
Beyond the preview
Go deeper on Sperm-I-Prove.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sperm-I-Prove.